Cargando…

The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms

Pancreatic cancer (pancreatic ductal adenocarcinoma, PDA) is infamously moving to the top of the list as one of the most lethal cancers with an overall 5 year survival rate of 7%. Multiple genomic-based and molecular characterization studies of PDA specimens and established animal models have provid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chand, Saswati, O'Hayer, Kevin, Blanco, Fernando F., Winter, Jordan M., Brody, Jonathan R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753156/ https://www.ncbi.nlm.nih.gov/pubmed/26929734 http://dx.doi.org/10.7150/ijbs.14951

Ejemplares similares

Acceptance and Commitment Therapy with Pancreatic Cancer: An Integrative Model of Palliative Care—A Case Report
por: O'Hayer, Catherine Virginia F., et al.
Publicado: (2018)

Building a Life Worth Living During a Pandemic and Beyond: Adaptations of Comprehensive DBT to COVID-19()
por: O'Hayer, C. Virginia
Publicado: (2021)

WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner
por: Lal, Shruti, et al.
Publicado: (2016)

HER-2-Positive Ampullary Adenocarcinoma: A Case Report
por: O'Hayer, Kevin, et al.
Publicado: (2015)

Metabolic Dependencies in Pancreatic Cancer
por: Vaziri-Gohar, Ali, et al.
Publicado: (2018)

Corrigendum: Metabolic Dependencies in Pancreatic Cancer
por: Vaziri-Gohar, Ali, et al.
Publicado: (2019)

Provider experiences of virtual reality in clinical treatment
por: Vincent, Christine, et al.
Publicado: (2021)

CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer
por: Iyengar, Mangala, et al.
Publicado: (2018)

Behavioral Health for the Front Line: Lessons from the Covid-19 Pandemic
por: O’Hayer, C. Virginia, et al.
Publicado: (2021)

584. Investigation of the Association Between Neurocognitive Function and Depression in HIV Infection
por: Mumford, Brigid, et al.
Publicado: (2018)

Sampling from single-cell observations to predict tumor cell growth in-vitro and in-vivo
por: Pearson, Alexander T., et al.
Publicado: (2017)

Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells
por: Jimbo, Masaya, et al.
Publicado: (2015)

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
por: Parkin, Ashleigh, et al.
Publicado: (2018)

Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics
por: Bessa, Cláudia, et al.
Publicado: (2020)

The glycosylation landscape of pancreatic cancer
por: Munkley, Jennifer
Publicado: (2019)

Current Landscape: The Mechanism and Therapeutic Impact of Obesity for Breast Cancer
por: Zhao, Chongru, et al.
Publicado: (2021)

Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance
por: Ashrafi, Adnin, et al.
Publicado: (2022)

The biological underpinnings of therapeutic resistance in pancreatic cancer
por: Beatty, Gregory L., et al.
Publicado: (2021)

Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology
por: Bazzichetto, Chiara, et al.
Publicado: (2020)

Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
por: Ciernikova, Sona, et al.
Publicado: (2020)

Genomic Landscapes of Pancreatic Neoplasia
por: Wood, Laura D., et al.
Publicado: (2015)

Right Ventricular Dysfunction in Critically Ill Patients With COVID-19
por: Brenner, Samantha K., et al.
Publicado: (2022)

Deciphering the genomic and lncRNA landscapes of aerobic glycolysis identifies potential therapeutic targets in pancreatic cancer
por: Zhu, Li-Li, et al.
Publicado: (2021)

Noncoding RNAs Associated with Therapeutic Resistance in Pancreatic Cancer
por: Son, Seung Wan, et al.
Publicado: (2021)

Pancreatic cancer cachexia: a review of mechanisms and therapeutics
por: Tan, Carlyn R., et al.
Publicado: (2014)

Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities
por: Liu, Dahai, et al.
Publicado: (2023)

Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma
por: Malvi, Parmanand, et al.
Publicado: (2022)

A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2
por: Nevler, Avinoam, et al.
Publicado: (2018)

Embracing the Landscape of Therapeutics
Publicado: (2020)

The Landscape and Therapeutic Targeting of BRCA1, BRCA2 and Other DNA Damage Response Genes in Pancreatic Cancer
por: Voutsadakis, Ioannis A., et al.
Publicado: (2023)

BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer
por: Pishvaian, Michael J, et al.
Publicado: (2017)

Randomized Phase 3 Trial of Ruxolitinib for COVID-19–Associated Acute Respiratory Distress Syndrome*
por: Rein, Lindsay, et al.
Publicado: (2022)

The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance
por: Patil, Kalyani, et al.
Publicado: (2021)

A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
por: Winter, Jordan M., et al.
Publicado: (2012)

Evolving treatment landscape for early and advanced pancreatic cancer
por: Lau, Sally C, et al.
Publicado: (2017)

Global landscape of 2-hydroxyisobutyrylation in human pancreatic cancer
por: Lu, Yun, et al.
Publicado: (2022)

Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus Fungi
por: Hagiwara, Daisuke, et al.
Publicado: (2016)

Mechanisms of antibiotic action shape the fitness landscapes of resistance mutations
por: Hemez, Colin, et al.
Publicado: (2022)

Identification of a lncRNA based signature for pancreatic cancer survival to predict immune landscape and potential therapeutic drugs
por: Ma, Di, et al.
Publicado: (2022)

Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
por: Winter, Jordan M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h8dl8msa05uu2nnfsdfadrm3mv